XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Impairment, restructuring and other charges | 6 Months Ended
--- | ---
Dec. 31, 2018
Impairment, restructuring and other charges |
Impairment, restructuring and other charges | 5. Impairment, restructuring and other charges Impairment During the three and six months ended December 31, 2018, there were no impairment charges. During the three and six months ended December 31, 2017, we (i) abandoned a product line in our Security division that became redundant as a result of the ETD acquisition, (ii) abandoned a non-core product line in our Healthcare division, and (iii) abandoned certain trademarks in our Optoelectronics and Manufacturing division that were no longer used. As a result, $3.1 million of assets, including intangible and fixed assets, were written off as we determined that these assets have no value and were permanently impaired. Restructuring and Other Charges We endeavor to align our global capacity and infrastructure with demand by our customers and also to fully integrate acquisitions, and thereby improve operational efficiency. We intiated a restructuring during fiscal 2019 in our Healthcare division in order to realign the organization and enable further investment in priority areas, and we have incurred associated charges of approximately $3.3 million and $3.5 million for the three and six months ended December 31, 2018, respectively. During the three and six months ended December 31, 2018, we recovered certain legal costs related to class action litigation and government investigations through insurance reimbursement. This resulted in a net credit to restructuring and other charges in our Corporate segment of $4.6 million and $1.0 million for the three and six months ended December 31, 2018, respectively. During the three and six months ended December 31, 2017, we incurred professional fees of $0.2 million and $0.9 million, respectively, to complete the ETD acquisition. During the three months ended December 31, 2017, we accrued $4.3 million of litigation and estimated settlement costs, $4.2 million of which was recorded in our Healthcare division. The following table summarizes impairment, restructuring and other charges for the periods set forth below (in thousands):
|  | Three Months Ended December 31, 2017
|  |  |  |  |  |  |  | Optoelectronics and |  |  |  |  |  |
|  |  |  |  | Healthcare |  | Manufacturing |  |  |  |  |  |
|  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Impairment charges |  | $ | 1,490 |  | $ | 579 |  | $ | 1,075 |  | $ | — |  | $ | 3,144
Acquisition-related costs |  |  | — |  |  | — |  |  | — |  |  | 361 |  |  | 361
Employee termination costs |  |  | 90 |  |  | — |  |  | 146 |  |  | — |  |  | 236
Facility closures/consolidation |  |  | 11 |  |  | 243 |  |  | — |  |  | — |  |  | 254
Legal and accrued settlement costs, net |  |  | — |  |  | 4,200 |  |  | — |  |  | 102 |  |  | 4,302
Total expensed |  | $ | 1,591 |  | $ | 5,022 |  | $ | 1,221 |  | $ | 463 |  | $ | 8,297
|  | Three Months Ended December 31, 2018
|  |  |  |  |  |  |  | Optoelectronics and |  |  |  |  |  |
|  |  |  |  | Healthcare |  | Manufacturing |  |  |  |  |  |
|  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Acquisition-related costs |  | $ | — |  | $ | — |  | $ | 20 |  | $ | — |  | $ | 20
Employee termination costs |  |  | (46) |  |  | 1,227 |  |  | 26 |  |  | — |  |  | 1,207
Facility closures/consolidation |  |  | — |  |  | 2,108 |  |  | — |  |  | — |  |  | 2,108
Legal and accrued settlement costs, net |  |  | — |  |  | — |  |  | — |  |  | (4,600) |  |  | (4,600)
Total expensed |  | $ | (46) |  | $ | 3,335 |  | $ | 46 |  | $ | (4,600) |  | $ | (1,265)
|  | Six Months Ended December 31, 2017
|  |  |  |  |  |  |  | Optoelectronics and |  |  |  |  |  |
|  |  |  |  | Healthcare |  | Manufacturing |  |  |  |  |  |
|  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Impairment charges |  | $ | 1,490 |  | $ | 579 |  | $ | 1,075 |  | $ | — |  | $ | 3,144
Acquisition-related costs |  |  | — |  |  | — |  |  | — |  |  | 1,181 |  |  | 1,181
Employee termination costs |  |  | 330 |  |  | — |  |  | 146 |  |  | — |  |  | 476
Facility closures/consolidation |  |  | 81 |  |  | 243 |  |  | — |  |  | — |  |  | 324
Legal and accrued settlement costs, net |  |  | — |  |  | 4,200 |  |  | — |  |  | 102 |  |  | 4,302
Total expensed |  | $ | 1,901 |  | $ | 5,022 |  | $ | 1,221 |  | $ | 1,283 |  | $ | 9,427
|  | Six Months Ended December 31, 2018
|  |  |  |  |  |  |  | Optoelectronics and |  |  |  |  |  |
|  |  |  |  | Healthcare |  | Manufacturing |  |  |  |  |  |
|  | Security Division |  | Division |  | Division |  | Corporate |  | Total
Acquisition-related costs |  | $ | — |  | $ | — |  | $ | 287 |  | $ | — |  | $ | 287
Employee termination costs |  |  | — |  |  | 1,418 |  |  | 133 |  |  | — |  |  | 1,551
Facility closures/consolidation |  |  | — |  |  | 2,108 |  |  | — |  |  | — |  |  | 2,108
Legal and accrued settlement costs, net |  |  | — |  |  | — |  |  | — |  |  | (1,015) |  |  | (1,015)
Total expensed |  | $ | — |  | $ | 3,526 |  | $ | 420 |  | $ | (1,015) |  | $ | 2,931
The changes in the accrued liability for restructuring and other charges for the six month period ended December 31, 2018 were as follows (in thousands):
|  |  |  |  |  |  |  | Facility |  |  |  |  |
|  |  |  | Employee |  | Closure/ |  |  |  |  |
|  | Acquisition- |  | Termination |  | Consolidation |  | Legal |  |  |
|  | related Costs |  | Costs |  | Cost |  | Charges |  | Total
Balance as of June 30, 2018 |  | $ | — |  | $ | 837 |  | $ | 399 |  | $ | 14,065 |  | $ | 15,301
Restructuring and other charges,net |  |  | 287 |  |  | 1,551 |  |  | 2,108 |  |  | (1,015) |  |  | 2,931
Payments and other adjustments |  |  | (287) |  |  | (1,589) |  |  | (2,078) |  |  | (861) |  |  | (4,815)
Balance as of December 31, 2018 |  | $ | — |  | $ | 799 |  | $ | 429 |  | $ | 12,189 |  | $ | 13,417

X
- Definition The entire disclosure for impairment, restructuring and related activities. Description of impairment costs and restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References No definition available. + Details
Name: | osis_ImpairmentRestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | osis_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringCostsAndAssetImpairmentChargesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration